Published in Cancer Weekly, June 21st, 2011
"To study the accuracy of Tc-99m-AnxV imaging, we monitored chemo-sensitive and chemo-resistant tumors in a mouse breast cancer model after treatment with docetaxel. Sensitive tumors showed a slight peak in Tc-99m-AnxV uptake one day post-treatment, while uptake in resistant tumors remained constant," wrote C.A.C. Beekman and colleagues, Antoni Van Leeuwenhoek Hospital.
The researchers concluded: "In contrast to immunohistochemical analysis, Tc-99m-AnxV imaging could not be used to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.